P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma

Bibliographic Details
Main Authors: Eleonora Calabretta, Martina Di Trani, Martina Sollini, Francesca Ricci, Francesco Corrado, Vanessa Cristaldi, Stefanos Bonovas, Fabrizio Marino, Rita Mazza, Lodovico Terzi Di Bergamo, Alessio Bruscaggin, Maria Cristina Pirosa, Stefania Bramanti, Arturo Chiti, Armando Santoro, Davide Rossi, Carmelo Carlo-Stella
Format: Article
Language:English
Published: Wiley 2022-10-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000891000.99990.30
_version_ 1797287782816677888
author Eleonora Calabretta
Martina Di Trani
Martina Sollini
Francesca Ricci
Francesco Corrado
Vanessa Cristaldi
Stefanos Bonovas
Fabrizio Marino
Rita Mazza
Lodovico Terzi Di Bergamo
Alessio Bruscaggin
Maria Cristina Pirosa
Stefania Bramanti
Arturo Chiti
Armando Santoro
Davide Rossi
Carmelo Carlo-Stella
author_facet Eleonora Calabretta
Martina Di Trani
Martina Sollini
Francesca Ricci
Francesco Corrado
Vanessa Cristaldi
Stefanos Bonovas
Fabrizio Marino
Rita Mazza
Lodovico Terzi Di Bergamo
Alessio Bruscaggin
Maria Cristina Pirosa
Stefania Bramanti
Arturo Chiti
Armando Santoro
Davide Rossi
Carmelo Carlo-Stella
author_sort Eleonora Calabretta
collection DOAJ
first_indexed 2024-03-07T18:39:53Z
format Article
id doaj.art-f2e5e94b80cb4f989e13cc4427596614
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T18:39:53Z
publishDate 2022-10-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-f2e5e94b80cb4f989e13cc44275966142024-03-02T04:19:17ZengWileyHemaSphere2572-92412022-10-016505110.1097/01.HS9.0000891000.99990.30202210005-00108P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphomaEleonora Calabretta0Martina Di Trani1Martina Sollini2Francesca Ricci3Francesco Corrado4Vanessa Cristaldi5Stefanos Bonovas6Fabrizio Marino7Rita Mazza8Lodovico Terzi Di Bergamo9Alessio Bruscaggin10Maria Cristina Pirosa11Stefania Bramanti12Arturo Chiti13Armando Santoro14Davide Rossi15Carmelo Carlo-Stella161 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy2 Department of Oncology and Hematology, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy2 Department of Oncology and Hematology, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy4 Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland4 Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland5 Oncology Institute of Southern Switzerland, Bellinzona, Switzerland2 Department of Oncology and Hematology, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italy4 Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland1 Department of Biomedical Sciences, Humanitas University, Rozzano, Milano, Italyhttp://journals.lww.com/10.1097/01.HS9.0000891000.99990.30
spellingShingle Eleonora Calabretta
Martina Di Trani
Martina Sollini
Francesca Ricci
Francesco Corrado
Vanessa Cristaldi
Stefanos Bonovas
Fabrizio Marino
Rita Mazza
Lodovico Terzi Di Bergamo
Alessio Bruscaggin
Maria Cristina Pirosa
Stefania Bramanti
Arturo Chiti
Armando Santoro
Davide Rossi
Carmelo Carlo-Stella
P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma
HemaSphere
title P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma
title_full P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma
title_fullStr P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma
title_full_unstemmed P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma
title_short P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma
title_sort p108 integrating baseline circulating tumor dna with interim pet improves outcome prediction in relapsed refractory classical hodgkin lymphoma
url http://journals.lww.com/10.1097/01.HS9.0000891000.99990.30
work_keys_str_mv AT eleonoracalabretta p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT martinaditrani p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT martinasollini p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT francescaricci p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT francescocorrado p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT vanessacristaldi p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT stefanosbonovas p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT fabriziomarino p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT ritamazza p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT lodovicoterzidibergamo p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT alessiobruscaggin p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT mariacristinapirosa p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT stefaniabramanti p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT arturochiti p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT armandosantoro p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT daviderossi p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT carmelocarlostella p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma